The arrival of Retatrutide in the UK is generating significant excitement within the weight loss community. This novel dual compound – targeting both GLP-1 and GIP – promises a remarkably new approach to addressing obesity . As of now , options have been constrained for many, and Retatrutide represents a promising prospect for patients seeking